Treatment of diabetes focuses on lowering blood sugar or glucose (BG) to the near normal range, approximately 80–140 mg/dl (4.4–7.8 mmol/L).
Veliki svetovni proizvajalci so Eli Lilly, Novo Nordisk in Sanofi-Aventis.